Virbac : Public release of the Half-Year Financial Report at 30 June 2026
The Group released and filed its 2026 half-year financial report with the French “Autorité des marchés financiers”.
The document is also available on the corporate website, at corporate.virbac.com, under “Investors”, “Financial Reports”.
MELBOURNE, Fla., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Orion180 Insurance Group Inc. ("Orion180"), a leading provider of flexible, customer-centric homeowners and flood insurance solutions, today announced the pricing of its initial public offering of 20,000,000 shares of its Class A common stock, at an initial public offering price of $12.00 per share. In addition, Orion180 has granted the underwriters a 30-day option to purchase up to an additional 3,000,000 shares of Class A common stock at the
MELBOURNE, Fla., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Orion180 Insurance Group Inc. ("Orion180"), a leading provider of flexible, customer-centric homeowners and flood insurance solutions, today announced the pricing of its initial public offering of 20,000,000 shares of its Class A common stock, at an initial public offering price of $12.00 per share. In addition, Orion180 has granted the underwriters a 30-day option to purchase up to an additional 3,000,000 shares of Class A common stock at the
Not for distribution to United States newswire services or for dissemination in the United States TORONTO, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Stardust Metal Corp. (TSXV:ZIGY) (" Stardust " or the " Company ") is pleased to announce that it has entered into an agreement with Canaccord Genuity Corp. (" Canaccord "), as lead agent and sole bookrunner, on behalf of a syndicate of agents to be formed (collectively, the " Agents "), in connection with a "best efforts" private placement offering for ag
THIS PRESS RELEASE IS NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES . CALGARY, Alberta, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Westgate Energy Inc. (the “ Company ” or “ Westgate ”) (TSXV: WGT) is pleased to announce that, due to investor demand, it has entered into an amended agreement with Haywood Securities Inc. (“ Haywood ” or the “ Underwriter ”) as sole underwriter and bookrunner, to increase the size of its previously announced “bought deal
VANCOUVER, British Columbia, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Vortex Energy Corp. (CSE: VRTX) (OTC: VTECF) (FSE: AA3) (“ Vortex ” or the “ Company ”) is pleased to announce that it has entered into an asset purchase agreement (the “ Asset Purchase Agreement ”) with Global Strategic Minerals Corp. (the “ Vendor ”), pursuant to which the Company will acquire (the “ Transaction ”) the Purchased Assets (as defined below) comprising the Meadows Project (the “ Project ”) located in west-central Sask
LOUISVILLE, Ky., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Churchill Downs Incorporated (Nasdaq: CHDN, “CDI,” “the Company”) announced today that it successfully priced its previously announced $500 million in aggregate principal amount of senior secured Term Loan B due 2033 (“2033 TLB”). The 2033 TLB priced at SOFR plus 175 basis points and issued at 99.875% of the principal amount. CDI intends to use the net proceeds from 2033 TLB (i) to repay outstanding Term Loan B loans, (ii) to repay outstanding
Not for distribution to U.S. newswire services nor for dissemination to the United States All amounts in Canadian dollars BROOKFIELD NEWS, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Brookfield Office Properties Inc., a subsidiary of Brookfield Property Partners L.P., today announced an extension to the conversion privilege on its Class AAA Preference Shares, Series R (“Series R Shares”) (TSX: BPO.PR.R) to September 23, 2026. Holders of Series R Shares have the right, at their option, exercisable no late
LOUISVILLE, Ky., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Onco360 ® , the nation’s leading independent Specialty Pharmacy, has been selected as a national pharmacy partner by AstraZeneca for Etcamah™ (camizestrant), which is indicated for the treatment of adult patients with hormone receptor (HR)-positive, HER2-negative, locally advanced or metastatic breast cancer upon detection of ESR1 mutation during aromatase inhibitor (AI) and CDK4/6 inhibitor therapy, based on a US Food and Drug Administration (
Comments (0)
Login to join the conversation
Login / RegisterNo comments yet. Be the first to comment!